In a filing, Voyager Therapeutics Inc revealed its Chief Scientific Officer Carter Todd Alfred unloaded Company’s shares for reported $14079.0 on Feb 20 ’25. In the deal valued at $4.26 per share,3,305 shares were sold. As a result of this transaction, Carter Todd Alfred now holds 77,718 shares worth roughly $0.31 million.
Then, Sandrock Alfred sold 11,702 shares, generating $49,616 in total proceeds. Upon selling the shares at $4.24, the President and CEO now owns 296,816 shares.
Before that, Swartz Robin sold 3,894 shares. Voyager Therapeutics Inc shares valued at $16,550 were divested by the COO & CBO at a price of $4.25 per share. As a result of the transaction, Swartz Robin now holds 98,397 shares, worth roughly $0.39 million.
Cantor Fitzgerald initiated its Voyager Therapeutics Inc [VYGR] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Leerink Partners started covering the stock on October 16, 2024. It rated VYGR as “an Outperform”.
Price Performance Review of VYGR
On Tuesday, Voyager Therapeutics Inc [NASDAQ:VYGR] saw its stock fall -4.80% to $3.97. Over the last five days, the stock has gained 0.25%. Voyager Therapeutics Inc shares have fallen nearly -29.98% since the year began. Nevertheless, the stocks have fallen -57.94% over the past one year. While a 52-week high of $10.66 was reached on 01/07/25, a 52-week low of $3.80 was recorded on 03/04/25. SMA at 50 days reached $4.99, while 200 days put it at $6.60.
Levels Of Support And Resistance For VYGR Stock
The 24-hour chart illustrates a support level at 3.85, which if violated will result in even more drops to 3.72. On the upside, there is a resistance level at 4.14. A further resistance level may holdings at 4.31. The Relative Strength Index (RSI) on the 14-day chart is 34.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.19%. Stochastics %K at 50.50% indicates the stock is a holding.
The most recent change occurred on March 26, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $22 price target.
